Goldman Sachs Group Inc Annexon, Inc. Transaction History
Goldman Sachs Group Inc
- $580 Billion
- Q2 2024
A detailed history of Goldman Sachs Group Inc transactions in Annexon, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 596,191 shares of ANNX stock, worth $3.91 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
596,191
Previous 562,966
5.9%
Holding current value
$3.91 Million
Previous $4.04 Million
27.63%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding ANNX
# of Institutions
158Shares Held
102MCall Options Held
3.61MPut Options Held
1.08M-
Bain Capital Life Sciences Investors, LLC Boston, MA8.45MShares$55.3 Million8.98% of portfolio
-
Satter Management Co., L.P.7.41MShares$48.5 Million76.44% of portfolio
-
Bvf Inc San Francisco, CA7MShares$45.9 Million1.05% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$43.1 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA6.43MShares$42.1 Million2.05% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $312M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...